(Q34282077)

English

Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

1 reference

based on heuristic

inferred from title

object named as

Ulrich Salzer

3

0 references

4

object named as

Klaus Warnatz

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Nils Venhoff

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Nora M Effelsberg

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Hans Hartmut Peter

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Dirk Lebrecht

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Michael Schlesier

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Reinhard E Voll

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Jens Thiel

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

21 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

e37626

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

copyright license

Creative Commons Attribution 4.0 International

21 May 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357389

6 July 2018

Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357389

6 July 2018

Pathogenesis of ANCA-associated vasculitis, an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357389

6 July 2018

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357389

6 July 2018

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357389

6 July 2018

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357389

6 July 2018

Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357389

6 July 2018

Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357389

6 July 2018

Practice parameter for the diagnosis and management of primary immunodeficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357389

6 July 2018

Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357389

6 July 2018

Staphylococcus aureus and Wegener's granulomatosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357389

6 July 2018

Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357389

6 July 2018

The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357389

6 July 2018

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037626

21 January 2018

The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357389

6 July 2018

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037626

21 January 2018

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037626

21 January 2018

The American College of Rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis)

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037626

21 January 2018

Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037626

21 January 2018

Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037626

21 January 2018

Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037626

21 January 2018

Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037626

21 January 2018

BAFF is elevated in serum of patients with Wegener's granulomatosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22629432

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22629432

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs

1 reference

https://pubmed.ncbi.nlm.nih.gov/22629432

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production

1 reference

https://pubmed.ncbi.nlm.nih.gov/22629432

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/22629432

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjögren's syndrome: a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22629432

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of different refractory systemic vasculitides treated with rituximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/22629432

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22629432

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Cyclophosphamide upon the Immune Response in Wegener's Granulomatosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22629432

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction

1 reference

https://pubmed.ncbi.nlm.nih.gov/22629432

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0037626

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2012PLoSO...737626V

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34282077&oldid=1962788056"